296 related articles for article (PubMed ID: 25089809)
21. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis.
Upadhayaya RS; Vandavasi JK; Vasireddy NR; Sharma V; Dixit SS; Chattopadhyaya J
Bioorg Med Chem; 2009 Apr; 17(7):2830-41. PubMed ID: 19285414
[TBL] [Abstract][Full Text] [Related]
22. Ring-substituted quinolines as potential anti-tuberculosis agents.
Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
24. Antimycobacterial activity evaluation, time-kill kinetic and 3D-QSAR study of C-(3-aminomethyl-cyclohexyl)-methylamine derivatives.
Kumar D; Raj KK; Bailey M; Alling T; Parish T; Rawat DS
Bioorg Med Chem Lett; 2013 Mar; 23(5):1365-9. PubMed ID: 23357633
[TBL] [Abstract][Full Text] [Related]
25. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.
Chander S; Ashok P; Cappoen D; Cos P; Murugesan S
Chem Biol Drug Des; 2016 Oct; 88(4):585-91. PubMed ID: 27203404
[TBL] [Abstract][Full Text] [Related]
27. Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents.
Tseng CH; Tung CW; Wu CH; Tzeng CC; Chen YH; Hwang TL; Chen YL
Molecules; 2017 Jun; 22(6):. PubMed ID: 28621733
[TBL] [Abstract][Full Text] [Related]
28. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
[TBL] [Abstract][Full Text] [Related]
29. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
Raja S; Prakash CR
Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and binary QSAR study of antitubercular quinolylhydrazides.
Manvar A; Khedkar V; Patel J; Vora V; Dodia N; Patel G; Coutinho E; Shah A
Bioorg Med Chem Lett; 2013 Sep; 23(17):4896-902. PubMed ID: 23876988
[TBL] [Abstract][Full Text] [Related]
32. Rational drug design based synthesis of novel arylquinolines as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Ray M; Rajan MG
Bioorg Med Chem Lett; 2013 Nov; 23(22):6097-105. PubMed ID: 24095091
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of novel 4-nitropyrrole-based semicarbazide and thiosemicarbazide hybrids with antimicrobial and anti-tubercular activity.
Rane RA; Naphade SS; Bangalore PK; Palkar MB; Shaikh MS; Karpoormath R
Bioorg Med Chem Lett; 2014 Jul; 24(14):3079-83. PubMed ID: 24878195
[TBL] [Abstract][Full Text] [Related]
36. Conformationally-constrained indeno[2,1-c]quinolines--a new class of anti-mycobacterial agents.
Upadhayaya RS; Lahore SV; Sayyed AY; Dixit SS; Shinde PD; Chattopadhyaya J
Org Biomol Chem; 2010 May; 8(9):2180-97. PubMed ID: 20401395
[TBL] [Abstract][Full Text] [Related]
37. C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.
Saquib M; Gupta MK; Sagar R; Prabhakar YS; Shaw AK; Kumar R; Maulik PR; Gaikwad AN; Sinha S; Srivastava AK; Chaturvedi V; Srivastava R; Srivastava BS
J Med Chem; 2007 Jun; 50(13):2942-50. PubMed ID: 17542574
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives.
Mamolo MG; Falagiani V; Zampieri D; Vio L; Banfi E; Scialino G
Farmaco; 2003 Sep; 58(9):631-7. PubMed ID: 13679155
[TBL] [Abstract][Full Text] [Related]
40. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
